In an otherwise healthy adult with a suspected uncomplicated acute bacterial sinus infection, is amoxicillin or azithromycin the preferred treatment?

Amoxicillin is Superior to Azithromycin for Uncomplicated Acute Bacterial Sinus Infections

Amoxicillin (with or without clavulanate) should be prescribed as first-line therapy for suspected uncomplicated acute bacterial rhinosinusitis (ABRS) in otherwise healthy adults, not azithromycin. Multiple major guidelines consistently recommend amoxicillin as the preferred agent, while azithromycin is notably absent from first-line recommendations 1, 2, 1.

Why Amoxicillin Wins

The American Academy of Otolaryngology–Head and Neck Surgery explicitly states that clinicians should prescribe amoxicillin with or without clavulanate as first-line therapy for 5 to 10 days for most adults with ABRS 1, 2. This recommendation is based on:

• Superior microbiologic coverage: Amoxicillin effectively targets the primary pathogens causing ABRS: Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis 3
• Proven efficacy: Grade A evidence from systematic reviews of randomized controlled trials supports amoxicillin's effectiveness 1, 2
• Narrow spectrum: Using a narrow-spectrum antibiotic reduces the risk of bacterial resistance 1, 2
• Cost-effectiveness: Amoxicillin is significantly less expensive than azithromycin 2

The Problem with Azithromycin

Azithromycin (a macrolide) is not recommended as first-line therapy for ABRS. The evidence reveals critical issues:

• Overuse without justification: More than 80% of ambulatory sinusitis visits result in antibiotic prescriptions, with macrolides being the most commonly prescribed—yet most of these prescriptions are unnecessary 3
• Absence from guidelines: No major guideline recommends azithromycin as first-line therapy for uncomplicated ABRS 1, 3, 2, 1, 3
• Inferior spectrum: While azithromycin showed comparable cure rates in older small studies 4, it lacks the targeted coverage that amoxicillin provides for the most common pathogens

When to Consider Watchful Waiting Instead

Before prescribing any antibiotic, consider that most acute rhinosinusitis is viral and self-limited. The number needed to treat with antibiotics is 18 for one additional cure, while the number needed to harm is only 8 3.

Reserve antibiotics for patients with:

• Symptoms persisting >10 days without improvement
• Severe symptoms: fever >39°C (102°F) with purulent nasal discharge or facial pain for ≥3 consecutive days
• "Double sickening": worsening after initial improvement 3

For patients who don't meet these criteria, offer watchful waiting with symptomatic treatment (saline irrigation, analgesics, decongestants) and provide a delayed antibiotic prescription to fill only if symptoms don't improve after 7 days 1, 2, 1.

Practical Prescribing Algorithm

If antibiotics are indicated:

1. First-line: Amoxicillin 500 mg three times daily OR 875 mg twice daily for 5-10 days 1, 2

2. Consider amoxicillin-clavulanate (875/125 mg twice daily) if:

   • Recent antibiotic use (within past month)
   • Severe or protracted symptoms
   • Failed prior antibiotic therapy
   • High local resistance rates
   • Comorbidities (diabetes, immunocompromised)
   • Age >65 years 2

3. For penicillin allergy: Doxycycline or respiratory fluoroquinolone (levofloxacin/moxifloxacin)—NOT azithromycin as first choice 3, 2

Recent Evidence Confirms Amoxicillin's Position

A 2026 large retrospective cohort study of over 500,000 patients found no difference in treatment failure between amoxicillin-clavulanate and amoxicillin alone (3.0% vs 3.1%), but amoxicillin-clavulanate had higher rates of secondary infections including yeast infections and C. difficile 5. This supports using plain amoxicillin for uncomplicated cases.

Common Pitfalls to Avoid

• Don't prescribe azithromycin reflexively because it's "easier" (once daily dosing). The convenience doesn't justify inferior guideline support
• Don't use antibiotics for symptoms <10 days unless severe criteria are met—most cases are viral 3
• Don't order imaging routinely—it doesn't distinguish bacterial from viral causes and increases costs 4-fold 3
• Don't forget symptomatic treatment: Intranasal corticosteroids and saline irrigation provide meaningful relief and may reduce antibiotic need 3, 6

Bottom line: Amoxicillin is the evidence-based first-line choice for ABRS. Azithromycin lacks guideline support and should not be used as initial therapy for uncomplicated acute bacterial sinusitis in adults.